Caterina De Benedittis

Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

Simona Soverini, Caterina De Benedittis, Kateřina Machová Poláková et al. · Blood · 2013 · 162 citations · Full text

Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement

Simona Soverini, Caterina De Benedittis, Cristina Papayannidis et al. · Cancer · 2013 · 138 citations · Full text

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study

Simona Soverini, Luana Bavaro, Caterina De Benedittis et al. · Blood · 2019 · 96 citations · Full text

Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase

Kateřina Machová Poláková, Vojtěch Kulvait, Adela Benesova et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 77 citations · Full text

Bioinformatics, Chronic Phase, Radiation Oncology +13

Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients

Lisa Pieri, Patrizia Bonadonna, Chiara Elena et al. · American Journal of Hematology · 2016 · 65 citations · Full text